Yuntai Fund

Yuntai Fund

Yuntai Fund was established in Beijing in 2014 by a group of investment professionals led by Partner Li Xiang. The firm operates as a domestic renminbi-denominated private equity manager, drawing its limited partner base largely from Chinese government guidance funds, state-owned enterprises, and onshore institutional investors. This RMB-centric structure distinguishes Yuntai from the dollar-fund peers that dominate China venture headlines, positioning it closer to industrial policy capital flows than to Silicon Valley-style venture deployment. The firm's strategy spans early-stage venture, growth equity, and buyout transactions, with a concentrated focus on hard technology and enterprise digitization. Yuntai deploys capital across enterprise software, industrial automation, artificial intelligence, digital health, and mobility. Its venture practice seeds companies at the pre-Series A stage, while the growth and buyout team targets controlling or significant minority stakes in mid-sized Chinese technology companies with proven unit economics and government procurement relationships. The firm's team size and assets under management are not publicly disclosed. Yuntai Fund is headquartered in Beijing, with no confirmed additional offices as of mid-2026. Its principal, Li Xiang, has been associated with the firm since its founding year, though detailed professional biographies are not published on the firm's limited website. In recent years, Yuntai has been an active participant in Beijing's Zhongguancun technology ecosystem, a cluster the Chinese government has prioritized for semiconductor, artificial intelligence, and advanced manufacturing self-sufficiency. Yuntai Fund's structural differentiator is its near-exclusive reliance on domestic RMB fundraising in a market where brand-name Chinese venture firms typically market parallel dollar and RMB vehicles. By aligning squarely with government guidance funds and state-backed LPs, the firm gains preferred access to strategically sensitive deal flow — particularly in semiconductors, defense-adjacent industrial tech, and healthcare data — that dollar-denominated funds face regulatory hurdles in pursuing. This posture makes Yuntai a more accurate barometer of Beijing's industrial technology priorities than of global LP sentiment.